NVL-330 is a selective, brain-penetrant inhibitor of oncogenic HER2 exon 20 insertion mutations in preclinical models

K.L. Andrews, Y. Sun, B. Gerard,A. Tangpeerachaikul,S. Mente, R.A. Kemper,C.M. Martin, N.E. Kohl, J.C. Horan,H.E. Pelish

European Journal of Cancer(2022)

引用 0|浏览7
暂无评分
关键词
oncogenic her2 exon,insertion mutations,inhibitor,brain-penetrant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要